Published in Blood on March 15, 1995
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A (1999) 1.75
PIG-A mutations in normal hematopoiesis. Blood (2005) 1.27
Glycosylphosphatidylinositol (GPI)-anchored surface antigens in the allogeneic activation of T cells. Clin Exp Immunol (1995) 0.82
Paroxysmal nocturnal haemoglobinuria: nature's gene therapy? Mol Pathol (2002) 0.77
Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria. J Clin Pathol (2002) 0.75
Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol (1988) 4.06
Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci U S A (1985) 3.42
Enhancement of ferroelectricity in strained BaTiO3 thin films. Science (2004) 3.35
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity (1996) 2.96
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia (2012) 2.78
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med (2001) 2.56
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature (1985) 2.51
The GroE chaperonin machine is a major modulator of the CIRCE heat shock regulon of Bacillus subtilis. EMBO J (1997) 2.50
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS (1999) 2.47
The IgG Fc receptor family. Ann Hematol (1998) 2.28
CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol (2001) 2.13
Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia (2005) 2.08
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science (1985) 1.83
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
The activation of female sex hormones: alpha-Oestradiol and its di-esters. Biochem J (1938) 1.69
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol (1991) 1.68
GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology (2012) 1.67
Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.64
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med (1986) 1.63
Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis. Arthritis Rheum (1991) 1.56
Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest (1993) 1.53
The activation of female sex hormones: Oestrone and its esters. The output of activity and efficiency coefficient. Biochem J (1938) 1.49
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol (1998) 1.49
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
A mass in the eye. Lancet (2002) 1.46
Chronic headache resulting from postoperative supraorbital neuralgia. Anesth Analg (1991) 1.45
Isoprene and acetone concentration profiles during exercise on an ergometer. J Breath Res (2009) 1.43
Biology of GPI anchors and pathogenesis of paroxysmal nocturnal hemoglobinuria. Immunol Today (1994) 1.43
Towards a better definition of human leucocyte surface molecules. Immunol Today (1989) 1.42
[Does treatment with thrombocyte aggregation inhibitors modify kidney transplantation surgery?]. Urologe A (1998) 1.41
FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood (1998) 1.40
Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases. Clin Nephrol (1993) 1.40
Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J Exp Med (1985) 1.37
The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol (1994) 1.36
Association of multiple sclerosis with ILT6 deficiency. Genes Immun (2005) 1.34
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J (1999) 1.33
Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol (2000) 1.31
Characterization of functional surface structures on human natural killer cells. Adv Immunol (1988) 1.30
Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum (2004) 1.29
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis (1998) 1.27
Specific release of proteoglycans from human natural killer cells during target lysis. Nature (1985) 1.26
Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice. Blood (1999) 1.25
Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes. Biol Chem (1999) 1.25
Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J Immunol (2001) 1.24
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol (1997) 1.24
Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 1.22
Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J Immunol (1985) 1.22
Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat (2006) 1.21
CD16- CD56+ natural killer cells after bone marrow transplantation. Blood (1992) 1.21
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
Chelation in medicine. Sci Am (1966) 1.20
Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab (1996) 1.19
Slit-lamp-adapted optical coherence tomography of the anterior segment. Graefes Arch Clin Exp Ophthalmol (2000) 1.19
The glycosylphosphatidylinositol-linked Fc gamma receptor III represents the dominant receptor structure for immune complex activation of neutrophils. Eur J Immunol (1992) 1.18
Changes of natural killer cells during acute psychological stress. J Clin Immunol (1993) 1.18
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell (1997) 1.18
Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants. J Biol Chem (1992) 1.17
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res (2001) 1.17
Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol (1993) 1.17
A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J Immunol (2000) 1.17
Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. Crit Care Med (2000) 1.16
Simultaneous detection of TDT-mediated dUTP-biotin nick end-labeling (TUNEL)-positive cells and multiple immunohistochemical markers in single tissue sections. Biotechniques (1995) 1.16
Incorporation of ganglioside analogues into fibroblast cell membranes. A spin-label study. Biochemistry (1983) 1.15
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis (2005) 1.15
Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol (2001) 1.14
Role of nerve growth factor in the adult dorsal root ganglia neuron and its response to injury. J Comp Neurol (1984) 1.14
Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol (1998) 1.13
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia (2008) 1.13
Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol (2001) 1.12
Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes. Eur J Immunol (1986) 1.12
Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis (2009) 1.11
Discussion paper: The naming of Potato virus Y strains infecting potato. Arch Virol (2007) 1.11
Dynamic association of trigger factor with protein substrates. J Mol Biol (2001) 1.11
Characteristics and uses of natural killer cells. Immunol Today (1988) 1.09
Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun (2007) 1.08
Corneal optical coherence tomography before and immediately after excimer laser photorefractive keratectomy. Am J Ophthalmol (2000) 1.08
The -6.1-kilobase chicken lysozyme enhancer is a multifactorial complex containing several cell-type-specific elements. Mol Cell Biol (1992) 1.08
The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding. J Immunol (1996) 1.08
Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci (1990) 1.07
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia. Ann Oncol (2011) 1.07
Fc gamma RIII-mediated production of TNF-alpha induces immune complex alveolitis independently of CXC chemokine generation. J Immunol (2001) 1.06
Mapping of two ugp genes coding for the pho regulon-dependent sn-glycerol-3-phosphate transport system of Escherichia coli. J Bacteriol (1982) 1.06
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol (1994) 1.05
Enhancement of natural killer function through activation of the T11 E rosette receptor. J Clin Invest (1987) 1.05
Increase of renal cell carcinoma incidence in central Europe. Eur Urol (1998) 1.04
Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur J Immunol (2000) 1.04
Systemic pathology of chimpanzees. J Med Primatol (1975) 1.04
Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity. J Exp Med (1986) 1.04
Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun (2007) 1.04
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet (1981) 1.02
Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood (1994) 1.02
Patients' attitude to subcutaneous immunoglobulin substitution as home therapy. J Clin Immunol (2006) 1.02
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol (1985) 1.02